Accendra Health, Inc. ACH
0.27 USD +0.01 (+2.77%)
Nov 3, 2026, 3:52 PM EST
0.2459 Day range 0.2898
0.20 52-week range 3.89
- YTD
- -90.33%
- 1 year
- -92.15%
Analyst view
Consensus: hold
Hold
Price target (mean) 5.44 +1908.9% upside
Now 0.2708
- Target (low)
- 4.00
- Target (mean)
- 5.44
- Target (high)
- 7.00
Ratings (0m) 5 1 buy · 2 hold · 2 sell
- Strong buy0
- Buy1
- Hold2
- Sell0
- Strong sell2
Recommendation trend
- This month 5
- 1 month ago 6
- 2 months ago 6
- 3 months ago 5
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 0.22235 | 0.22 – 0.23145 | 0.55 | -59.6% | 714.79M | -73.5% | 5 |
| Next quarter | 0.15329 | 0.14658 – 0.16 | 0.23 | -33.4% | 654.27M | -75.1% | 2 |
| Current year | 1.01 | 0.95 – 1.06 | 1.53 | -33.7% | 3.16B | -70.5% | 5 |
| Next year | 0.97202 | 0.82488 – 1.14 | 1.01 | -4.2% | 2.62B | -17.2% | 5 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Nov 3, 2025 | UBS | Downgrade | Buy | Neutral |
| Aug 27, 2025 | JP Morgan | Maintained | Underweight | Underweight |
| Aug 13, 2025 | UBS | Maintained | Buy | Buy |
| Aug 12, 2025 | Baird | Maintained | Outperform | Outperform |
| Aug 12, 2025 | Citigroup | Maintained | Buy | Buy |
| Aug 12, 2025 | B of A Securities | Maintained | Underperform | Underperform |